middle.news
Vitrafy’s No-Wash Platelet Cryopreservation Clears US Army Phase II Hurdle
10:00am on Thursday 1st of January, 1970 AEST
•
Healthcare
Read Story
Vitrafy’s No-Wash Platelet Cryopreservation Clears US Army Phase II Hurdle
10:00am on Thursday 1st of January, 1970 AEST
Key Points
94% post-thaw platelet recovery with no-wash 3% DMSO protocol
Outperformance on clot strength and receptor retention
Largest commercial-scale platelet testing by US Army
No FDA-approved frozen platelet products currently available
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Vitrafy Life Sciences (ASX:VFY)
OPEN ARTICLE